Parachute A Treatment for Heart Failure

Know More
Watch Video click to watch video
Caution: Investigational Device. Limited by United States law to investigational use.

Parachute A Treatment for Heart Failure

Know More
Watch Video click to watch video
Caution: Investigational Device. Limited by United States law to investigational use.

Parachute A Treatment for Heart Failure

Know More
"The greatest thing about it was
that I could do more. Being retired,
I was in no hurry to do anything,
but I could do a lot more.
I could do things. I could walk further.
I could do and accomplish more at
one time without having to sit down
and rest." - Dean Tackett
Caution: Investigational Device. Limited by United States law to investigational use.
×
×

Welcome to CardioKinetix

The Company, based in Menlo Park, CA, has developed a novel transcatheter implant called the Parachute™ Ventricular Partitioning Device (Parachute™). The Parachute™ intends to treat heart failure resulting from a heart attack in patients worldwide by improving overall cardiac function.

Press Releases

  • 7 May 2012

    Maria Sainz Joins CardioKinetix

    Brings Proven Record of Success in Commercializing Innovative Therapies

    Menlo Park, Calif – CardioKinetix Inc, a


    View More
  • 7 May 2012

    CardioKinetix Announces Late Breaking

    Two-Year Data on Breakthrough Treatment to be Presented on Friday, May 18

    Menlo Park, Calif —


    View More
  • 27 April 2012

    CardioKinetix Wins Edison Award

    Awards Honor Innovation, Creativity and Ingenuity

    Menlo Park, CA – CardioKinetix Inc, a pioneer in catheter-based treatments for


    View More

“We continue to be encouraged by the early clinical results demonstrated by the ParachuteTM implant.  In all of our previous studies we have seen similar improvements in treated heart failure patients.”

Thomas Engels, Vice President of Clinical Affairs of CardioKinetix Inc.